Skip to main content

Table 3 Comparison of the IVF/ICSI cycle outcomes between two groups

From: Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial

Variable

Group A

(Prolutex)

(n = 40)

Group B

(Cyclogest)

(n = 40)

p-value

Fertilization rate (mean ± SD)

71.7 ± 22.0

73.2 ± 25.6

0.77

Implantation rate (mean ± SD)

52.8 ± 19.8

73.0 ± 26.8

0.015*

Chemical pregnancy rate/ET

(24/40) 60.5

(15/40) 38.5

0.045*

Clinical pregnancy rate/ET, n (%)

(40/23) 57.5

(40/13) 32.5

0.025*

Multiple pregnancy rate, n (%)

2/23 (8.7)

6/13 (46.1)

0.009*

Miscarriage rate, n (%)

2/23 (8.7)

1/13 (7.7)

0.92

  1. IVF/ICSI, in vitro fertilization/intracytoplasmic sperm injection; ET, embryo transfer. The quantitative and qualitative variables are presented as mean (standard deviation) and number (percentage), respectively.*P-value less than 0.05, there was a significant difference between the two groups